1. |
Ono H, Kondo H, Gotoda T, et al. Endoscopic mucosal resection for treatment of early gastric cancer. Gut, 2001, 48(2): 225-229.
|
2. |
Chung IK, Lee JH, Lee SH, et al. Therapeutic outcomes in 1000 cases of endoscopic submucosal dissection for early gastric neoplasms: Korean ESD Study Group multicenter study. Gastrointest Endosc, 2009, 69(7): 1228-1235.
|
3. |
Watanabe K, Ogata S, Kawazoe S, et al. Clinical outcomes of EMR for gastric tumors: Historical pilot evaluation between endoscopic submucosal dissection and conventional mucosal resection. Gastrointest Endosc, 2006, 63(6): 776-782.
|
4. |
Shin WG, Kim SJ, Choi MH, et al. Can rebamipide and proton pump inhibitor combination therapy promote the healing of endoscopic submucosal dissection-induced ulcers? A randomized, prospective, multicenter study. Gastrointest Endosc, 2012, 75(4): 739-747.
|
5. |
Lee SY, Kim JJ, Lee JH, et al. Healing rate of EMR-induced ulcer in relation to the duration of treatment with omeprazole. Gastrointest Endosc, 2004, 60(2): 213-217.
|
6. |
Oh TH, Jung HY, Choi KD, et al. Degree of healing and healing-associated factors of endoscopic submucosal dissection-induced ulcers after pantoprazole therapy for 4 weeks. Dig Dis Sci, 2009, 54(7): 1494-1499.
|
7. |
Kim YG, Jang BI, Kim TN. A matched case-control study of a novel acid-pump antagonist and proton-pump inhibitor for the treatment of iatrogenic ulcers caused by endoscopic submucosal dissection. Gut Liver, 2010, 4(1): 25-30.
|
8. |
Kato T, Araki H, Onogi F, et al. Clinical trial: rebamipide promotes gastric ulcer healing by proton pump inhibitor after endoscopic submucosal dissection—a randomized controlled study. J Gastroenterol, 2010, 45(3): 285-290.
|
9. |
Jeong HK, Park CH, Jun CH, et al. A prospective randomized trial of either famotidine or pantoprazole for the prevention of bleeding after endoscopic submucosal dissection. J Korean Med Sci, 2007, 22: 1055-1059.
|
10. |
Uedo N, Takeuchi Y, Yamada T, et al. Effect of a proton pump inhibitor or an H2-receptor antagonist on prevention of bleeding from ulcer after endoscopic submucosal dissection of early gastric cancer: a prospective randomized controlled trial. Am J Gastroenterol, 2007, 102(8): 1610-1616.
|
11. |
Ohya TR, Endo H, Kawagoe K, et al. A prospective randomized trial of lafutidine vs rabeprazole on post-ESD gastric ulcers. World J Gastrointest Endosc, 2010, 2(1): 36-40.
|
12. |
Imaeda H, Hosoe N, Suzuki H, et al. Effect of lansoprazole versus roxatidine on prevention of bleeding and promotion of ulcer healing after endoscopic submucosal dissection for superficial gastric neoplasia. J Gastroenterol, 2011, 46(11): 1267-1272.
|
13. |
Takeuchi N, Umegaki E, Takeuchi T, et al. Half-Dose Rabeprazole Has an Equal Efficacy to Standard-Dose Rabeprazole on Endoscopic Submucosal Dissection-Induced Ulcer. J Clin Biochem Nutr, 2011, 49(3): 216–221.
|
14. |
Tomita T, Kim Y, Yamasaki T, et al. A prospective randomized controlled trial to compare the effects of omeprazole and famotidine in preventing delayed bleeding and promoting ulcer healing after endoscopic submucosal dissection. J Gastroenterol Hepatol, 2012, doi: 10.1111/j.1440-1746.
|
15. |
Bañares R, Albillos A, Rincón D, et al. Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: a meta-analysis. Hepatology, 2002, 35(3): 609-615.
|
16. |
Oh JH, Choi MG, Dong MS, et al. Low-dose intravenous pantoprazole for optimal inhibition of gastric acid in Korean patients. J Gastroenterol Hepatol, 2007, 22(9): 1429-1434.
|
17. |
Ono S, Kato M, Ono Y, et al. Effects of preoperative administration of omeprazole on bleeding after endoscopic submucosal dissection: a prospective randomized controlled trial. Endoscopy, 2009, 41(4): 299-303.
|
18. |
Green FW Jr, Kaplan MM, Curtis LE, et al. Effect of acid and pepsin on blood coagulation and platelet aggregation. Gastroenterology, 1978, 74(1): 38-43.
|
19. |
Lee SY, Kim JJ, Lee JH, et al. Healing rate of EMR-induced ulcer in relation to the duration of treatment with omeprazole. Gastrointest Endosc, 2004, 60(2): 213–217.
|
20. |
Villanueva C, Blanzo J, Sainz S, et al. Omeprazole versus ranitidine as adjuct therapy to endoscopic injection in actively bleeding ulcer: a prospective and randomized study. Endoscopy, 1995, 27(4): 308-312.
|
21. |
Yacyshyn BR, Thomason ABR. Critical review of acid suppression in nonvariceal, acute, upper gastrointestinal bleeding. Dig Dis, 2000, 18(3): 117-128.
|
22. |
Stedman CA, Barclay ML. Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors. Aliment Pharmacol Ther, 2000, 14(8): 963-978.
|
23. |
Soetikno RM, Gotoda T, Nakanishi Y, et al. Endoscopic mucosal resection. Gastrointest Endosc, 2003, 57(4): 567-579.
|
24. |
Lin HJ, Lo WC, Lee FY, et al. A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcer after successful endoscopic therapy. Arch Intern Med, 1998, 158(1): 54-58.
|
25. |
Lau JY, Sung JJ, Lee KK, et al. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding ulcers. N Engl J Med, 2000, 343(5): 310-316.
|